Lasmiditan succinate is a pharmaceutical raw material used in the manufacturing of medications for migraine. It is taken orally and is not intended for migraine prevention.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 439239-92-6
Lasmiditan hydrochloride
pharmaceutical raw material
Lasmiditan
pharmaceutical raw material
Niflumic acid
pharmaceutical raw material
Eribulin mesylate
pharmaceutical raw material
Macitentan
pharmaceutical raw material
Sulfamide, N-[6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-5-(4-chlorophenyl)-4-pyrimidinyl]-N'-propyl-
pharmaceutical raw material
butanedioic acid;bis(2,4,6-trifluoro-N-[6-(1-methylpiperidine-4-carbonyl)-2-pyridinyl]benzamide)
MSOIHUHNGPOCTH-UHFFFAOYSA-N
CN1CCC(CC1)C(=O)C2=NC(=CC=C2)NC(=O)C3=C(C=C(C=C3F)F)F.CN1CCC(CC1)C(=O)C2=NC(=CC=C2)NC(=O)C3=C(C=C(C=C3F)F)F.C(CC(=O)O)C(=O)O